Please login to the form below

Not currently logged in
Email:
Password:

Ibuprofen could reduce Parkinson's risk

OTC painkillers such as ibuprofen may reduce the risk of developing Parkinson's disease, according to new research.

OTC painkillers such as ibuprofen may reduce the risk of developing Parkinson's disease, according to new research.

Regular use of OTC NSAIDs was associated with a 60 per cent reduction in the risk of developing Parkinson's disease, compared with occasional or non-use.

The study compared the use of aspirin and other NSAIDs in 579 men and women, half of whom had Parkinson's disease. Regular NSAID use was defined as taking two or more tablets a week for at least one month. Regular use of aspirin was associated with a 40 per cent reduction in risk, but only among women.

"Our findings suggest NSAIDs are protective against Parkinson's disease, with a particularly strong effect among regular users of non-aspirin NSAIDs, especially those who reported two or more years of use," commented study author Dr Anelika Wahner of the UCLA School of Public Health in Los Angeles.

The results are published in full in the 6 November 2007 issue of Neurology, the medical journal of the American Academy of Neurology.

30th September 2008

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
infill healthcare communication

infill is a dynamic and innovative, international healthcare agency with >25 years' experience in delivering healthcare communication, medical education and...

Latest intelligence

ema1
The European Medicines Agency: PRIME’d for access?
Leela Barham examines the impact of the EMA's PRIME fast track system after two years...
How can pharma engage with key stakeholders on NHS service transformation?
Steve How, Paul Midgley and Oli Hudson, of the Wilmington Healthcare consulting team, explain how pharma should make its case for change...
michael elliot
The race for an HIV ‘cure’
Supercharging therapies as pharma and patients work together...

Infographics